Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Stemline Therapeutics, Inc.
Seqker Biosciences, Inc.
VA Office of Research and Development
Augusta University
Icahn School of Medicine at Mount Sinai
Roswell Park Cancer Institute
Ludwig Institute for Cancer Research
University of Louisville
Icahn School of Medicine at Mount Sinai
Celldex Therapeutics
Celldex Therapeutics
University Hospital, Geneva
Rutgers, The State University of New Jersey